A new study suggests that AlphaFold, an AI trained by DeepMind, could be useful for drug discovery.
AlphaFold predicts protein structures based on the sequence of amino acids.
Researchers found that AlphaFold's predictions led to the identification of new compounds for drug discovery.
The hit rates for both traditional and AI-generated methods were similar in identifying compounds that could bind to proteins and alter their function.
The study's results need to be peer-reviewed and replicated by other labs, but if confirmed, AlphaFold could accelerate drug discovery.